Recombinant hCG (OVIDREL) and recombinant interferon-beta1a (REBIF) (No. 13 in a series of articles to promote a better understanding of the use of genetic engineering).
Explore the source record for details and available documents.
Animals↗
Biomedical subjects
D Piani
Publications and source records attributed to D Piani.
Effect of taurohyodeoxycholic acid on biliary lipid secretion in humans.
This study aimed to determine the effect in humans of taurohyodeoxycholic acid, a 6alpha-hydroxylated bile acid with hydrophilic properties, on bile lipid secretion. Four cholecystectomized patients who had gallstones and an interrupted enterohepatic circulation were intraduodenally infused with taurohyodeoxycholic and tauroursodeoxycholic acids on separate occasions at a dose of 0.8 to 1 g/h for 3 hours. In hourly bile samples collected for 8 hours after the beginning of the infusion, biliary bile acid composition (by high-performance liquid chromatography), biliary lipid concentrations (by standard methods), and distribution of biliary carriers (by gel chromatography) were evaluated. Blood liver function tests were performed before and after the infusions. Taurohyodeoxycholic and tauroursodeoxycholic acids became the predominant biliary bile acids in all patients except for one infused with taurohyodeoxycholic acid. Taurohyodeoxycholic acid stimulated significantly greater (P < .05) cholesterol and phospholipid secretion per unit of secreted bile acid (0.098 and 0.451 micromol/micromol, respectively) compared with tauroursodeoxycholic acid (0.061 micromol/micromol for cholesterol and 0.275 micromol/micromol for phospholipids). The secretory ratio between phospholipid and cholesterol was significantly higher after infusion of taurohyodeoxycholic acid (3.88 micromol/micromol) compared with taroursodeoxycholic acid (3.09 micromol/micromol) (P < .05). Biliary enrichment with taurohyodeoxycholic acid was positively related with percent concentration of phospholipids but not with that of cholesterol. The opposite trend was observed in tauroursodeoxycholic acid-enriched biles. In both taurohyodeoxycholic acid- and tauroursodeoxycholic acid-rich bile, 80% to 90% of cholesterol was carried in a gel-chromatographic fraction corresponding to an apparent molecular weight of 80 to 200 kd. No alteration in liver function test results was observed after taurohyodeoxycholic acid infusion. In conclusion, taurohyodeoxycholic acid stimulates greater cholesterol and phospholipid secretion than tauroursodeoxycholic acid, but with a higher phospholipid/cholesterol secretory ratio. In bile enriched with both bile acids, biliary cholesterol is transported in non-micellar aggregates. Finally, in the conditions of our study, taurohyodeoxycholic acid was not hepatotoxic.
Aged↗
Involvement of the cystine transport system xc- in the macrophage-induced glutamate-dependent cytotoxicity to neurons.
Macrophages have been found to release glutamate and thereby induce neuronal cell death by excitotoxicity, a mechanism that seems to be operative in various neurologic diseases. In this study, it is shown that the presence of both cystine and glutamine in the culture medium is indispensable for brain macrophages to release glutamate and to cause neuronal cell death. Furthermore, release of glutamate requires protein synthesis since cycloheximide prevented accumulation of the neurotoxic molecule in supernatants of microglial cell cultures. Aminoadipate, which was shown to inhibit the uptake of cystine by system xc- in fibroblasts, efficiently reduced the release of glutamate. The requirement of glutamine and cystine for the release of glutamate by microglial cells as well as the inhibitory effect observed with aminoadipate shows the transport system xc- to be essential for the release of the excitotoxin glutamate by microglial cells. Phagocytosis of zymosan particles and stimulation with different bacterial components, such as LPS, protein A, tuberculin, and Staphylococcus enterotoxin A increased glutamate release two- to threefold above basal values. In addition, the effect of bacterial components was mimicked by TNF-alpha, but not by IL-1 and IL-6. Cytokines known to deactivate macrophages, such as TGF-beta, IL-4, and IL-10, did not affect the transport system xc- in microglial cells. However, dexamethasone suppressed the glutamate release up to 50%.
Animals↗
Microglia and tumor rejection.
Explore the source record for details and available documents.
Brain Neoplasms↗
Glutamate uptake by astrocytes is inhibited by reactive oxygen intermediates but not by other macrophage-derived molecules including cytokines, leukotrienes or platelet-activating factor.
By their property to release glutamate and reactive oxygen intermediates, macrophages may play an important role in neurotoxicity. In the present study we have investigated whether macrophage-derived molecules also impair the detoxification of glutamate by astrocytes. Cytokines, including interleukin (IL)-1, 6 and 10, interferon (IFN)-alpha/beta, tumor necrosis factor (TNF)-alpha and transforming growth factor (TGF)-beta 1, as well as leukotriene (LT) B4 and C4, prostaglandin (PG) E2 and nitric oxide radicals had no effect on the uptake of [3H]glutamate by murine astrocytes in culture. In contrast, exposure of astrocytes to the enzyme glucose oxidase (100-200 mU ml-1), which maintains steady-state levels of hydrogen peroxide, reduced glutamate uptake by 30-50%. By their dual effect, comprising secretion of glutamate and inhibition of its detoxification by astrocytes, activated macrophages and microglial cells may contribute to exacerbate excitotoxic mechanisms in neurological diseases.
Animals↗
Immune-mediated injury in bacterial meningitis.
Cytokines are involved in the host response to bacterial infections. In bacterial meningitis, intrathecal synthesis of TNF-alpha and IL-1 is likely to contribute to CNS injury by recruitment and activation of inflammatory cells with subsequent release of toxic factors, such as reactive oxygen intermediates and excitatory amino acids (glutamate), leading to neuronal cell death with neurologic sequelae. In rats with experimental meningitis, pretreatment with TGF-beta inhibits cerebrovascular changes and brain edema formation in the early, TNF-alpha-independent phase. Provided its local production in bacterial infection, TGF-beta may comprise a host factor interfering with immune pathologic events altering the integrity of the endothelial barrier.
Animals↗
Granulocyte-macrophage colony-stimulating factor (GM-CSF) production by glioblastoma cells. Despite the presence of inducing signals GM-CSF is not expressed in vivo.
One of the morphologic hallmarks of human gliomas are inflammatory infiltrates with accumulation of macrophages in the tumor site. The signals leading to the macrophage response are only at the beginning of being understood. Novel chemotactic factors that have recently been characterized as secretory products of glioblastoma cells may attract mononuclear cells from the blood. Within the tumor tissue blood-derived monocytes and macrophages of the brain tissue, the microglial cells, may increase in cell numbers due to tumor-derived growth factors. Both astrocytoma cell lines and cultured astrocytes have been shown recently to produce granulocyte-macrophage (GM)-CSF. We show that in vitro not only astrocytoma but also glioblastoma cell lines secrete GM-CSF when stimulated with TNF-alpha or IL-1. However, there is no evidence for GM-CSF production by glioblastoma cells in vivo: fresh tumor samples lack the mRNA for GM-CSF and the protein is not detectable in the tumor cyst fluids or the cerebrospinal fluids of glioblastoma patients. This contrasts IL-1 and IL-6 that are detectable in the tumor cyst fluids and IL-6 also in the cerebrospinal fluids of the patients. Unlike GM-CSF, transforming growth factor-beta 2 mRNA is expressed in ex vivo tested glioblastoma tissues. Absence of GM-CSF in vivo may be explained by the presence of tumor-derived inhibitory factors, such as transforming growth factor-beta 2 and PGE which suppress GM-CSF production by glioblastoma cells in vitro. The accumulation of macrophages at the tumor site may be due to local elaboration of chemoattractants and/or not yet defined growth factors rather than due to GM-CSF production.
Chemotactic Factors↗
Macrophage-induced cytotoxicity of N-methyl-D-aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines.
The co-localization of activated macrophages and damaged neurons observed in brain injury and degenerative brain diseases may hint to macrophage-induced neuronal cytotoxicity. Recently, macrophages have been found to secrete neurotoxic molecules such as radical oxygen intermediates and glutamate, the latter interacting with N-methyl-D-aspartate (NMDA) receptors. As shown in the present study, brain macrophages termed microglial cells co-cultured with differentiated cerebellar neurons excert potent neurotoxic effects. Neurotoxicity is unlikely to be due to cytokines since tumor necrosis factor (TNF)-alpha, interleukin (IL)-1 beta, IL-6 and interferon (IFN)-alpha/IFN-beta/IFN-gamma had no such effects. In contrast, when treating neurons with H2O2 or oxygen radical-generating systems cytotoxicity was induced. Furthermore, microglia were found to produce O2- and H2O2 when triggered with phorbol 12-myristate 13-acetate. However, in co-cultures of neurons and microglia, oxygen-radical scavengers catalase and superoxide dismutase, failed to protect neurons from microglia-induced killing. Moreover, when using undifferentiated neurons which are susceptible to H2O2 but not to NMDA receptor-dependent killing, microglia did not destroy the neurons. Thus, the amount of reactive oxygen intermediates produced by microglia in co-culture do not reach the critical concentrations required for neurotoxicity. As dibenzocyclohepteneimide, an antagonist to NMDA receptors neutralized neurotoxicity in microglia-neuronal co-cultures, excitatory amino acids released by microglia are suggested to compose the major determinant of neurotoxicity.
Animals↗
Murine brain macrophages induced NMDA receptor mediated neurotoxicity in vitro by secreting glutamate.
Supernatants (SN) of brain macrophages in culture induce death of cerebellar granule cells in vitro, while those of astrocytes and endothelial cells do not. This toxicity can be prevented by N-methyl-D-aspartate (NMDA) receptor antagonists. Macrophage SN contain high concentrations of glutamate. Reducing the glutamate level of macrophage SN, either by exposure to astrocytes or by enzymatic degradation abolished the toxic effect. Thus, macrophage neurotoxicity is mediated by glutamate acting on NMDA receptors, and might play a role in vivo in traumatic and cerebrovascular brain lesions.
2-Amino-5-phosphonovalerate↗